Medscape Pathology (@MedscapePath) header
Medscape Pathology (@MedscapePath) profile picture

Medscape Pathology & Lab Medicine provides you with breaking medical news; reference on drugs, diseases, and procedures; and free CME.

Joined January 2010
Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)Photo by Medscape Pathology (@MedscapePath)
Struggling to choose between DNA vs. RNA-based NGS for NTRK fusions? Hear from the experts who explain why RNA-based assays, and plasma testing when tissue is limited, are critical for detection. Watch the full discussion ➡️ mdsc.pe/4jb6VFn #CME #Oncology
39
Starting in 1 HOUR ➡️ mdsc.pe/4k9208O Gain expert insights on NTRK fusions in lung and thyroid cancer. Join LIVE! 🗓️ Today ⏰ 12:00pm EST #Oncology #NTRKFusions #MedEd
1
32
LIVE TOMORROW ➡️ mdsc.pe/4k9208O Equip your practice with actionable insights on NTRK fusions in lung and thyroid cancer. 🗓️ November 6th ⏰ 12:00pm EST #Oncology #NTRKFusions #MedEd
1
46
Join our expert faculty LIVE as they discuss managing NTRK fusions in lung and thyroid cancer. 🗓️ November 6th ⏰ 12:00pm EST 🔗 mdsc.pe/4k9208O #Oncology #NTRKFusions #MedEd #CME #LungCancer
44
SAVE THE DATE 🗓️ Join Dr. Nabil F. Saba & Dr. Jarushka Naidoo to explore clinical care insights on NTRK fusions across lung & thyroid cancer. 🗓️ Oct 29 ⏰ 11:30am EST 🔗 mdsc.pe/4k9208O #Oncology #NTRKFusions
1
127
From early molecular testing to targeted therapy sequencing, our expert panel breaks down how identifying NTRK fusions transforms care in pediatric oncology. Watch the expert breakdown here ➡️ mdsc.pe/4xlHwgv #MedEd #CME #PrecisionMedicine
65
NTRK fusions are game changers in pediatric oncology, serving as actionable drivers that guide precision treatment strategies. Catch the replay ➡️ mdsc.pe/4xlHwgv #MedEd #CME #OncologyCare
47
Identifying an NTRK fusion as an oncogenic driver can completely redefine clinical management and treatment pathways for pediatric patients with rare tumors. Watch the full discussion ➡️ mdsc.pe/4xlHwgv #MedEd #CME #PediatricOncology
66
Starting in 1 HOUR ➡️ Ready to elevate patient care in NTRK fusion-positive cancers? Tune in live to get practice-oriented insights from expert faculty. ⏰ 2:00pm ET 🔗 mdsc.pe/45jrbg8 #Oncology #PrecisionMedicine #MedscapeEducation
31
LIVE TOMORROW ➡️ Explore emerging data & practical considerations for initiating therapy in NTRK fusion-positive cancers with expert faculty. Bring your Qs! 📅 July 31st ⏰ 2:00pm ET 🔗 mdsc.pe/45jrbg8 #Oncology #PrecisionMedicine #MedscapeEducation
42
How do you navigate treatment sequencing for NTRK fusion-positive cancers? Join our expert panel for a 15-min LIVE event on precision medicine in real-world care. 📅 July 31st ⏰ 2:00pm ET 🔗 mdsc.pe/45jrbg8 #Oncology #MedscapeEducation
51
SAVE THE DATE 🗓️ Join Dr. Sébastien Perreault & Dr. Michela Casanova live for insights into translating NTRK fusion data into real-world care across CNS, sarcoma, & pediatric cancers. 📅 July 31st ⏰ 2:00pm ET 🔗 mdsc.pe/45jrbg8 #Oncology #PrecisionMedicine
122
Medscape Pathology retweeted
Correcting the title of this presentation: It is actually... Tackling Cases of cSCC. How do YOU perform in patient simulations? You can watch it already in progress...
#MedscapeLIVE: "Improving Outcomes in Locally Advanced #NSCLC: The Role of Immune Checkpoint Inhibitors" at #ASCO19 pscp.tv/w/b8RQBDFlUkV4cExxbl…
11
13
Medscape Pathology retweeted
#MedscapeLIVE: "Improving Outcomes in Locally Advanced #NSCLC: The Role of Immune Checkpoint Inhibitors" at #ASCO19 pscp.tv/w/b8RQBDFlUkV4cExxbl…
1
25
3
41
Medscape Pathology retweeted
Medscape Poll: Are you fairly compensated compared to physicians in other specialties? Read, decide, vote. wb.md/2oDfezJ
22%Yes
57%No
21%Unsure
190 votes • Final results
2
15
2
24
Medscape Pathology retweeted
Medscape poll: This surgeon lied to protect a colleague. wb.md/2ldKAbb Would you? Read, decide, vote.
18%Yes
37%No
35%It depends
10%Unsure
419 votes • Final results
1
22
23
Medscape Pathology retweeted
Medscape Poll: If you had a do over, would you choose your medical specialty again? Read, decide, vote. wb.md/2kKZJ2O
52%Yes
23%No
13%Depends on the day
12%Unsure
665 votes • Final results
Medscape Pathology retweeted
Medscape Poll: What was the top medical story of 2016?
70%Zika
15%Opioids
13%Legal marijuana
2%Other (Leave a comment)
910 votes • Final results
4
37
3
30
Medscape Pathology retweeted
Developing: #Ebola Vaccine 100% Effective. Full story to follow.
3
83
5
74
Medscape Pathology retweeted
#Ebola vaccine found 100% effective in study. Full story. wb.md/2ioUiVY
6
101
10
78